Synthesis and Characterization of a New Bivalent Ligand Combining Caffeine and Docosahexaenoic Acid
Caffeine is a promising drug for the management of neurodegenerative diseases such as Parkinson’s disease (PD), demonstrating neuroprotective properties that have been attributed to its interaction with the basal ganglia adenosine A2A receptor (A2AR). However, the doses needed to exert these neuropr...
Main Authors: | Víctor Fernández-Dueñas, Jhonny Azuaje, Xavier Morató, Begoña Cordobilla, Joan Carles Domingo, Eddy Sotelo, Francisco Ciruela |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2017-02-01
|
Series: | Molecules |
Subjects: | |
Online Access: | http://www.mdpi.com/1420-3049/22/3/366 |
Similar Items
-
Alcohol abuse and docosahexaenoic acid: Effects on cerebral circulation and neurosurvival
by: Michael A Collins
Published: (2015-01-01) -
Triglyceride Form of Docosahexaenoic Acid Mediates Neuroprotection in Experimental Parkinsonism
by: Maricel Gómez-Soler, et al.
Published: (2018-08-01) -
Correlation Between Docosahexaenoic Acid Intake and It’s Content in Breast Milk of Lactating Mothers in Jakarta
by: Raphael Kosasih, et al.
Published: (2019-08-01) -
Influence of caffeine on blood pressure and platelet aggregation
by: José Wilson S. Cavalcante, et al.
Published: (2000-08-01) -
Docosahexaenoic acid and the preterm infant
by: Stephanie L. Smith, et al.
Published: (2017-12-01)